CONFLICT OF INTEREST STATEMENT The authors declare that Angelo D'Alessandro and Travis Nemkov are founders of Omix Technologies Inc. Angelo D'Alessandro and Travis Nemkov are Scientific Advisory Board (SAB) members for Hemanext Inc. Angelo D'Alessandro is a SAB member for Macopharma Inc. and SynthMed Bio. All the other authors have no conflicts to disclose in relation to this study. DATA AVAILABILITY STATEMENT All raw data and elaborations are included in the .xlsx.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Mars
Contact Mars, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack